Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Reexamination Certificate
2011-07-12
2011-07-12
Canella, Karen (Department: 1643)
Drug, bio-affecting and body treating compositions
Lymphokine
Interleukin
C424S085500, C424S085600, C424S085700, C424S649000, C514S016100
Reexamination Certificate
active
07976835
ABSTRACT:
Compositions and methods of preventing or treating a breast cancer are disclosed. The composition and method can utilize an endothelin B agonist and a chemotherapeutic agent as active ingredients to treat a solid tumor in mammals, including humans. Alternatively, the composition and method can utilize an endothelin B antagonist and an optional angiogenesis inhibitor to treat a solid tumor in mammals, including humans.
REFERENCES:
patent: 5550110 (1996-08-01), Cody et al.
patent: 5612359 (1997-03-01), Murugesan
patent: 5811416 (1998-09-01), Chwalisz et al.
patent: 2002/0082285 (2002-06-01), Lebwohl
patent: 2003/0104976 (2003-06-01), Davar et al.
patent: 0 655 463 (1995-05-01), None
patent: 0-815 870 (1998-01-01), None
patent: 0 950 418 (1999-10-01), None
patent: WO 96/19233 (1996-06-01), None
patent: WO 00/67024 (2000-11-01), None
patent: WO 01/00198 (2001-01-01), None
patent: WO 0100198 (2001-01-01), None
patent: WO 01/91736 (2001-12-01), None
patent: WO 03/009805 (2003-02-01), None
patent: WO 03/045434 (2003-06-01), None
Taxol® product Label (Feb. 10, 2000).
Bell et al. (International Journal of Cancer 1999; 80: 295-302).
Wu-Wong et al (The Journal of Pharmacology and Experimental therapeutics, 2000, vol. 293, pp. 514-521).
Murata et al (British Journal of Pharmacology, Apr. 2001, vol. 132, pp. 1365-1373).
Rowinsky et al. (N. Engl. J. Med. 1995; 332: 1004-1014).
D.J. Chaplin et al.,Seminars in Radiation Oncology, vol. 8, No. 3, pp. 151-163 (1998).
K.M. Bell et al.,Br. J. CancerSupp. 27:S161-3 (1996).
K.M. Bell et al.,Int. J. Cancer, 67(5):730-8 (1996).
K.M. Bell et el.,Int. J. Cancer, 73(2):283-9 (1997).
K.M. Bell et al.,Int. J. Cancer, 80(2):295-302 (1999).
K. Kikuchi et al.,Biochemical and Biophysical Research Communications, vol. 219, No. 3, 734-739 (1996).
A. Rai et al.,Cancer Chemother. Pharmacol., vol. 51, 21-28 (2002).
R. Lahav et al.,Proceedings of the National Academy of Sciences of USA, vol. 96, 11496-11500 (1999).
K.M. Bell et al.,Journal of Cardiovascular Pharmacology, vol. 26, No. s3, s222-s225 (1995).
D. DelBufalo et al.,Clinical Science, vol. 103, No. S48, 302S-305S (2002).
J.M. Kroodsma et al.,Nederlands Tijdschrift Voor Geneeskunde, vol. 141, No. 38, 1-3 (1997).
B. Battistini et al.,Drug News&Perspectives, vol. 8, No. 6, 365-391 (1995).
A.P. Davenport et al.,Clinical Science, vol. 103, No. S48, 1S-3S (2002).
K. Matsumaru et al.,J. Gastroenterol, 32, 164-170 (1997).
A.E. Duggan et al.,Aliment Pharmacol Ther, 13, 631-635 (1999).
A.S.C. Fabricio et al.,British Journal of Pharmacology, 125, 542-548 (1998).
K. Parfitt (ed)., “Martindale The complete drug reference (32nd Edition),” Pharmaceutical Press, 1999.
S. Bhalla et al.,Peptides, 23, 1837-1845 (2002).
H.N. Bhargava et al.,The Journal of Pharmacology and Experimental Therapeutics, vol. 252, No. 3, 901-907 (1990).
C. Wu,Exp. Opin. Ther. Patents, 10(11), 1653-1668 (2000).
M.F. Jarvis et al.,European Journal of Pharmacology, 388, 29-35 (2000).
G. Davar et al.,NeuroReport, 9, 2279-2283 (1998).
Davenport, International Union of Pharmacology. XXIX. Update on Endothelin Receptor Nomenclature, 2002, vol. 54, No. 2, pp. 219-226, Journal, Pharmacological Reviews, The American Society for Pharmacology and Experimental Therapeutics.
Canella Karen
Cullman Louis C.
K&L Gates LLP
Stathakis Dean G.
The Board of Trustees of the University of Illinois
LandOfFree
Methods and compositions for preventing and treating solid... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions for preventing and treating solid..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for preventing and treating solid... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2740265